Archives     Advertise     Editorial Calendar      Advertiser Index     Subscribe     Contact Us    



 

Erika Hamilton, MD

Director, Breast Cancer & Gynecologic Cancer Research | Sarah Cannon Research Institute

Partner | Tennessee Oncology

"The most influential individuals in my life are those who ignite curiosity and refrain from using the word 'no,'" said Erika Hamilton.

For someone who has spent her life pushing past the norms in a quest for improved cancer outcomes, it's important to be surrounded by 'can do' people. "It is vital to think outside the box and not take the current answer or statistic as the final word," she said of oncology care. "If we just become comfortable with the status quo, we will never advance care or propel new drug therapies forward."

Growing up in Charlotte, N.C., Hamilton said she knew from the age of five that she wanted to be a doctor and was fortunate to have family and teachers who said 'yes' to her interests. "Throughout school, I was lucky to have teachers who allowed me to pursue my curiosity in nontraditional ways - like dissecting frog brains in elementary school when it wasn't on the curriculum or helping me explore my passion for science ... even if that meant taking AP Biology a little ahead of my peers."

After completing her undergraduate studies at Washington and Lee University, Hamilton returned to her home state for medical school, internship and residency at the University of North Carolina Chapel Hill, followed by a fellowship at Duke University in nearby Durham. While she never wavered about her decision to be a doctor, Hamilton said she originally thought she might work in a pediatric field. "But I quickly realized that I enjoyed working with adults and helping them discover the empowerment that comes from understanding their situation and treatment options and finding a personalized plan that was right for them," she explained.

"When patients find the correct therapy, it's such a joy to watch their progress wildly exceed our expectations," Hamilton continued. "I also love celebrating the important milestones with them, whether that's their children getting married or even starting kindergarten."

Her responsibilities with Sarah Cannon Research Institute and Tennessee Oncology allow Hamilton to enjoy the best of both worlds by taking an active role in research while still engaging directly with patients two days a week. She's most passionate about the intersection of those two roles - clinical trials. "No advance in cancer has been made without a clinical trial," she stated unequivocally.

Hamilton said a misconception persists that clinical trials are for those who are out of options ... that it's a last line of therapy. Instead, she hopes people will think of it as a starting point. "That's something a patient should ask their doctor at diagnosis," she said. "I often tell my patients a clinical trial is a way to access the drugs we may be using five or 10 years from now." She's equally passionate about the Sarah Cannon mission to bring those cutting-edge clinical trials to patients in their own communities. "Patients shouldn't have to hop on a plane to get the latest care," she noted.

Hamilton is deeply appreciative of all who participate in trials without knowing all the answers ahead of time. "The bravery of the patients that come and participate in clinical trials, even with the uncertainty of the outcomes, is inspiring," she said. "It's incredibly special when that bravery is rewarded with clinical success, much like running into the end zone and scoring a touchdown!"

While the pandemic was undeniably disruptive, Hamilton said a silver lining was the increased time she and husband Justin, an Air Force pilot and squadron commander, had to spend with daughters Patten and Ellis, ages seven and four. Whether playing games in the park, backyard scavenger hunts or just doodling with sidewalk chalk in the drive, Hamilton said it was important to remember little things can be big fun. "This year has been a good reminder of the value of finding childhood joy and contentment in life's simplicities," Hamilton noted.

It's a perspective she plans to carry forward in her work. "Every single improvement is one additional stair on the staircase," she pointed out. New drugs, precision medicine, improved tolerance, fewer side effects - Hamilton said each advancement allows physicians to better care for patients and give them more simple moments with friends and family. "If we look back decade to decade, this type of progress is astounding from where we have come. Every step we take brings us closer to improving patients' quantity and quality of life."

 
Share:

Related Articles:


Recent Articles

AACR Establishes New Cancer Evolution Working Group

The American Association for Cancer Research (AACR) announced the formation of its seventh and newest scientific working group, which will be dedicated to supporting cancer evolution research.

Read More

Global Dementia Cases Forecasted To Triple By 2050

New analysis shows a decrease in prevalence due to education countered by increase due to heart health risk factors

Read More

Blackburn, Feinstein Introduce Bill to Protect Access to Breast Cancer Screenings

U.S. Senators Marsha Blackburn (R-Tenn.) and Dianne Feinstein (D-Calif.) today introduced the Protecting Access to Lifesaving Screenings (PALS) Act of 2021, a bill to preserve coverage for routine breast cancer screening for women beginning at age 40.

Read More

CUMBERLAND PHARMACEUTICALS REPORTS 2.5M PATIENT DOSES DELIVERED, NO PRODUCT RECALLS, NO FDA ISSUES IN 2020

The company's 2020 sustainability report highlights its commitment to environmental, social and governance (ESG) activities

Read More

Mobile Mentor Named Winner of Microsoft's 2021 Partner of the Year for Modern Endpoint Management

Mobile Mentor announced they have been awarded the 2021 Global Partner of the Year Award for Modern Endpoint Management.

Read More

Alzheimer's Association Welcomes CMS Announcement of National Coverage Determination Analysis on Treatment for Alzheimer's Disease

On behalf of all those living with Alzheimer's disease, their caregivers, and their families, we appreciate the Centers for Medicare & Medicaid Services (CMS) thoughtful consideration on coverage considerations for monoclonal antibodies targeting amyloid for the treatment of Alzheimer's disease, including aducanumab, which was recently approved by the Food and Drug Administration (FDA).

Read More

HCTec Acquires Talon Healthy IT Services

Healthcare IT firm adds industry-leading help desk service company to portfolio of solutions

Read More

The Seven Steps of Revenue Cycle for a Healthcare Practice

Revenue cycle management tracks patient revenue from the initial encounter with the healthcare system to payment of balance. Getting the seven steps of revenue cycle right helps providers avoid missteps that are costly to the bottom line.

Read More

Expanding Evidence-Based Care for Dementia

The Alzheimer's Association is on a mission to ensure care professionals have access to evidence-based training to ensure those with dementia receive quality care across all settings.

Read More

A Natural Leader

Nashville physician Dr. Ryan Mire to head nation's largest medical-specialty society.

Read More

Email Print
 
 

 

 


Tags:
None
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: